Understanding and improving care for leukodystrophies
Official title: Natural History, Diagnosis, and Outcomes for Leukodystrophies
Run by University of Utah · NCT03639285 · Data updated 2026-11-12
This study is trying to better understand and improve care for people with leukodystrophies by looking at their medical histories and outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | University of Utah Academic / other |
| Locations | 1 site (Salt Lake City, Utah) |
| Status | Recruiting |
| Started | January 19, 2007 |
| Main results expected | December 31, 2033 |
| Study ends | December 31, 2050 |
| Registry record updated | January 13, 2026 |
| Trial ID | NCT03639285 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals diagnosed with an inherited leukodystrophy who can travel to the clinic for evaluation.
✕Probably not a fit
Patients with non-genetic causes of their condition or those unable to be evaluated at the study locations may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to diagnose, care for, and analyze the clinical histories and outcomes of individuals with leukodystrophies, a group of inherited disorders affecting the brain's white matter. Conducted by the Western Leukodystrophy Project at the University of Utah and Primary Children's Hospital, the study seeks to provide specialized resources and treatment options for affected patients. By gathering data on clinical presentations and outcomes, the study hopes to enhance understanding and improve care guidelines for this complex condition.
Why it matters
Potential benefit: If successful, this study could lead to better diagnosis and treatment options for patients with leukodystrophies, ultimately improving their health outcomes.
How similar studies have gone: While similar studies have been conducted, this specific approach focusing on comprehensive care and outcomes for leukodystrophies is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * evidence by clinical exam, radiological findings, and/or testing, of an inherited leukodystrophy. * be able to travel to the leukodystrophy clinic (at Primary Children's Hospital, Salt Lake City, Utah); * be able to tolerate a general physical exam, and a neurological exam. Exclusion Criteria: * unable to be evaluated at the University of Utah Hospital or Primary Children's Hospital; * refusal to sign study consent form; * evidence or finding of another non-genetic cause of their condition; * Persons with known white matter disease or lesions related to: birth injury or prenatal injury, multiple sclerosis, trauma, infection, immunization, or post-infectious effects (e.g. ADEM- acute disseminated encephalomyelitis), metabolic disturbance (e.g. Central pontine myelinolysis), neoplasms, primary rheumatologic diseases (e.g. Systemic lupus erythematosis), stroke, hypoxic-ischemic injury, drug or toxin effect, seizures, or endocrine disturbance.
Where it's running
-
Primary Children's Hospital
Salt Lake City, Utah, United States Recruiting
Study contacts
- Study coordinator: Josh Bonkowsky, MD, PhD
- Email: joshua.bonkowsky@hsc.utah.edu
- Phone: 8012133599
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Home exercise program for people with neurodegenerative diseases
This study is testing a home exercise program to see if it can help people with neurodegenerative diseases improve their walking and balance.
-
Long-term observation of rare genetic brain disorders
This study is tracking how rare genetic brain disorders progress over time to better understand their effects on patients.
-
Collecting data and samples from patients with leukodystrophy
This study is collecting health information and samples from people with leukodystrophy to help find new causes and better treatments for the condition.
-
Registry for patients with rare diseases
This study is creating a central registry for people with rare diseases to help connect them with researchers and improve treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.